In vitro activity of paldimycin (U-70138F) against gram-positive bacteria isolated from patients with cancer
- PMID: 3606069
- PMCID: PMC174800
- DOI: 10.1128/AAC.31.4.650
In vitro activity of paldimycin (U-70138F) against gram-positive bacteria isolated from patients with cancer
Abstract
The in vitro activity of paldimycin, a novel antimicrobial agent, was compared with that of vancomycin against 306 gram-positive isolates (representing 12 bacterial species) obtained from patients with cancer. Paldimycin had lower MICs for 90% of isolates than vancomycin did against most isolates tested. Its activity, however, was medium and pH dependent, being greatest in Nutrient broth at a pH of 6.8.
Similar articles
-
In vitro activities of daptomycin (LY146032) and paldimycin (U-70,138F) against anaerobic gram-positive bacteria.Antimicrob Agents Chemother. 1988 May;32(5):788-90. doi: 10.1128/AAC.32.5.788. Antimicrob Agents Chemother. 1988. PMID: 2840019 Free PMC article.
-
In vitro susceptibility of gram-positive cocci to paldimycin.Antimicrob Agents Chemother. 1987 Jan;31(1):104-7. doi: 10.1128/AAC.31.1.104. Antimicrob Agents Chemother. 1987. PMID: 3105438 Free PMC article.
-
In vitro evaluation of the new paulomycin antibiotic paldimycin.Eur J Clin Microbiol. 1987 Jun;6(3):306-8. doi: 10.1007/BF02017620. Eur J Clin Microbiol. 1987. PMID: 3622497
-
Vancomycin resistance: are there better glycopeptides coming?Expert Rev Anti Infect Ther. 2008 Dec;6(6):917-28. doi: 10.1586/14787210.6.6.917. Expert Rev Anti Infect Ther. 2008. PMID: 19053904 Review.
-
Oritavancin: a new avenue for resistant Gram-positive bacteria.Expert Rev Anti Infect Ther. 2005 Jun;3(3):325-32. doi: 10.1586/14787210.3.3.325. Expert Rev Anti Infect Ther. 2005. PMID: 15954849 Review.
Cited by
-
In vitro activities of daptomycin (LY146032) and paldimycin (U-70,138F) against anaerobic gram-positive bacteria.Antimicrob Agents Chemother. 1988 May;32(5):788-90. doi: 10.1128/AAC.32.5.788. Antimicrob Agents Chemother. 1988. PMID: 2840019 Free PMC article.
-
Comparative in vitro activity of the two new 4-quinolones S-25930 and S-25932 against gram-positive bacteria isolated from cancer patients.Eur J Clin Microbiol Infect Dis. 1988 Oct;7(5):681-3. doi: 10.1007/BF01964254. Eur J Clin Microbiol Infect Dis. 1988. PMID: 3143584
-
World-wide development of antibiotic resistance in pneumococci.Eur J Clin Microbiol. 1987 Aug;6(4):367-77. doi: 10.1007/BF02013089. Eur J Clin Microbiol. 1987. PMID: 3311732 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical